Micron Technology found itself under the analytical scissors as UBS Group chopped its price target from $130 to $92, still ...

AT&T’s stock price ticked up a modest 0.4% after Barclays boosted its target from $27 to $30, giving it an overweight rating.

Elevance Health finds itself in a charmingly awkward “Moderate Buy” spotlight, courted by 17 analysts, 13 of whom are smitten ...

Burling Wealth Partners LLC has joined the real estate stampede by purchasing 14,242 shares of Prologis, valued around $1.5 ...

Shares of Citigroup enjoyed a 1.7% bump during mid-day trading, making Wall Street analysts dust off their calculators. Morgan Stanley, Truist Financial, and others adjusted price targets downward but ...

J. Safra Sarasin Holding AG has decided to take a first-class seat on Boeing’s financial flight, acquiring 5,654 shares ...

Bolthouse Investments dropped a cool $287,000 on TJX Companies during the fourth quarter, nabbing 2,378 shares of the ...

OneDigital Investment Advisors LLC trimmed its Deere & Company holdings by 13.6% during the fourth quarter, selling 911 ...

Vertex Pharmaceuticals is expected to report mixed results with declining earnings but rising revenues for Q1 2025. Analysts ...

Representative George Whitesides recently cleaned house, selling off shares of Lockheed Martin and other major corporations.

NewEdge Advisors LLC significantly reduced its stake in Regeneron Pharmaceuticals, shedding shares like unwanted holiday weight. The firm sold 1,630 shares, cutting its holdings by 36.8%, leaving it ...

Bristol-Myers Squibb managed to surpass revenue expectations by a comfortable 4.6%, yet suffered an inconvenient earnings ...